Local Recurrence and Survival in Soft-tissue Sarcomas
Overview
Affiliations
Background: There is a continuous interest in the literature concerning the management and survival after treatment of local recurrence in sarcomas because it is one of the most common types of recurrence.
Design: We retrospectively reviewed 93 patients treated for local recurrence from soft-tissue sarcoma.
Methods: We evaluated prognostic parameters (grade, tumor size, location) and the effect of treatment on survival.
Results: Resection of all the gross tumor at first visit to our Institute for local recurrence was accomplished in 88 patients (95%). Of the 59 patients with extremity tumors, six (10%) required an amputation. At a mean follow-up of 66 months, further local recurrence was noted in 27%. The estimated 5-year survival rate was 100% for patients with grade I tumors (n = 16), 77% for grade II (n = 31), and 45% for grade III tumors (n = 46) (p = 0.0002). This value was 78% for tumors < or = 5 cm and 57% for those > 5 cm (p = 0.03).
Conclusions: Local recurrence is resectable and limb preservation is possible in the majority of patients. The overall 5-year survival rate was 65%. Survival after treatment of local recurrence is determined mainly by the grade and secondarily by the size of the tumor as for primary sarcomas.
Rethinking tumor viability as prognostic factor in soft tissue sarcoma.
Montreuil J, Kholodovsky E, Markowitz M, Torralbas Fitz S, Campano D, Erik Geiger J J Orthop. 2025; 68:7-14.
PMID: 39980706 PMC: 11836483. DOI: 10.1016/j.jor.2025.01.030.
Principles of Surgical Treatment of Soft Tissue Sarcomas.
Gonzalez M, Mendez-Guerra C, Goh M, Pretell-Mazzini J Cancers (Basel). 2025; 17(3).
PMID: 39941773 PMC: 11816134. DOI: 10.3390/cancers17030401.
Sacchetti F, Alsina A, Muratori F, Scoccianti G, Neri E, Kaya H J Orthop. 2023; 42:74-79.
PMID: 37533628 PMC: 10391603. DOI: 10.1016/j.jor.2023.07.002.
Local recurrence management of extremity soft tissue sarcoma.
Serban B, Cretu B, Cursaru A, Nitipir C, Orlov-Slavu C, Cirstoiu C EFORT Open Rev. 2023; 8(8):606-614.
PMID: 37526250 PMC: 10441250. DOI: 10.1530/EOR-23-0095.
Sacchetti F, Alsina A, Morganti R, Innocenti M, Andreani L, Muratori F J Orthop. 2021; 25:244-251.
PMID: 34099954 PMC: 8165293. DOI: 10.1016/j.jor.2021.05.022.